{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,2,21]],"date-time":"2025-02-21T03:25:24Z","timestamp":1740108324902,"version":"3.37.3"},"reference-count":14,"publisher":"Springer Science and Business Media LLC","issue":"9","license":[{"start":{"date-parts":[[2018,5,22]],"date-time":"2018-05-22T00:00:00Z","timestamp":1526947200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Eur J Clin Pharmacol"],"published-print":{"date-parts":[[2018,9]]},"DOI":"10.1007\/s00228-018-2485-6","type":"journal-article","created":{"date-parts":[[2018,5,22]],"date-time":"2018-05-22T02:27:41Z","timestamp":1526956061000},"page":"1191-1192","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":6,"title":["Acute kidney injury, agranulocytosis, drug-induced liver injury, and posterior reversible encephalopathy syndrome caused by high-dose methotrexate\u2014possible role of low activity ABC and SLC drug transporters"],"prefix":"10.1007","volume":"74","author":[{"given":"L.","family":"Bielen","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"I.","family":"Kralj","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1563-7421","authenticated-orcid":false,"given":"Ela","family":"\u0106ur\u010di\u0107","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.","family":"Vodanovi\u0107","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A.","family":"Boban","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"N.","family":"Bo\u017eina","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2018,5,22]]},"reference":[{"issue":"27","key":"2485_CR1","doi-asserted-by":"publisher","first-page":"2691","DOI":"10.1056\/NEJMc1507547","volume":"373","author":"AP Garneau","year":"2015","unstructured":"Garneau AP, Riopel J, Isenring P (2015) Acute methotrexate-induced crystal nephropathy. N Engl J Med 373(27):2691\u20132693","journal-title":"N Engl J Med"},{"issue":"11","key":"2485_CR2","doi-asserted-by":"publisher","first-page":"1479","DOI":"10.2217\/pgs.14.97","volume":"15","author":"S Suthandiram","year":"2014","unstructured":"Suthandiram S, Gan GG, Zain SM, Bee PC, Lian LH, Chang KM, Ong TC, Mohamed Z (2014) Effect of polymorphisms within methotrexate pathway genes on methotrexate toxicity and plasma levels in adults with hematological malignancies. Pharmacogenomics 15(11):1479\u20131494","journal-title":"Pharmacogenomics"},{"issue":"3","key":"2485_CR3","doi-asserted-by":"publisher","first-page":"659","DOI":"10.1124\/dmd.112.049254","volume":"41","author":"L Li","year":"2013","unstructured":"Li L, Agarwal S, Elmquist WF (2013) Brain efflux index to investigate the influence of active efflux on brain distribution of pemetrexed and methotrexate. Drug Metab Dispos 41(3):659\u2013667","journal-title":"Drug Metab Dispos"},{"key":"2485_CR4","doi-asserted-by":"publisher","unstructured":"Martinez D, Muhrez K, Woillard JB, Berthelot A, Gyan E, Choquet S, Andr\u00e8s CR, Marquet P, Barin-Le Guellec C (2017) Endogenous metabolites-mediated communication between OAT1\/OAT3 and OATP1B1 may explain the association between SLCO1B1 SNPs and methotrexate toxicity. Clin Pharmacol Ther. \n                    https:\/\/doi.org\/10.1002\/cpt.1008","DOI":"10.1002\/cpt.1008"},{"issue":"26","key":"2485_CR5","doi-asserted-by":"publisher","first-page":"5145","DOI":"10.1182\/blood-2013-01-480335","volume":"121","author":"S Radtke","year":"2013","unstructured":"Radtke S, Zolk O, Renner B, Paulides M, Zimmermann M, M\u00f6ricke A, Stanulla M, Schrappe M, Langer T (2013) Germline genetic variations in methotrexate candidate genes are associated with pharmacokinetics, toxicity, and outcome in childhood acute lymphoblastic leukemia. Blood 121(26):5145\u20135153","journal-title":"Blood"},{"issue":"4","key":"2485_CR6","doi-asserted-by":"publisher","first-page":"377","DOI":"10.1007\/BF00315414","volume":"39","author":"C Wolfrom","year":"1990","unstructured":"Wolfrom C, Hepp R, Hartmann R, Breithaupt H, Henze G (1990) Pharmacokinetic study of methotrexate, folinic acid and their serum metabolites in children treated with high-dose methotrexate and leucovorin rescue. Eur J Clin Pharmacol 39(4):377\u2013383","journal-title":"Eur J Clin Pharmacol"},{"issue":"2","key":"2485_CR7","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1097\/FPC.0b013e32834ded2a","volume":"22","author":"KP Spyridopoulou","year":"2012","unstructured":"Spyridopoulou KP, Dimou NL, Hamodrakas SJ, Bagos PG (2012) Methylene tetrahydrofolate reductase gene polymorphisms and their association with methotrexate toxicity: a meta-analysis. Pharmacogenet Genomics 22(2):117\u2013133","journal-title":"Pharmacogenet Genomics"},{"issue":"5","key":"2485_CR8","doi-asserted-by":"publisher","first-page":"1445","DOI":"10.1007\/s13277-012-0395-2","volume":"33","author":"L Yang","year":"2012","unstructured":"Yang L, Hu X, Xu L (2012) Impact of methylenetetrahydrofolate reductase (MTHFR) polymorphisms on methotrexate-induced toxicities in acute lymphoblastic leukemia: a meta-analysis. Tumour Biol 33(5):1445\u20131454","journal-title":"Tumour Biol"},{"issue":"9","key":"2485_CR9","first-page":"3807","volume":"30","author":"R Santucci","year":"2010","unstructured":"Santucci R, Leveque D, Lescoute A, Kemmel V, Herbrecht R (2010) Delayed elimination of methotrexate associated with co-administration of proton pump inhibitors. Anticancer Res 30(9):3807\u20133810","journal-title":"Anticancer Res"},{"issue":"3","key":"2485_CR10","doi-asserted-by":"publisher","first-page":"565","DOI":"10.1111\/bcp.12384","volume":"78","author":"DJ Reeves","year":"2014","unstructured":"Reeves DJ, Moore ES, Bascom D, Rensing B (2014) Retrospective evaluation of methotrexate elimination when co-administered with proton pump inhibitors. Br J Clin Pharmacol 78(3):565\u2013571","journal-title":"Br J Clin Pharmacol"},{"key":"2485_CR11","doi-asserted-by":"publisher","first-page":"321","DOI":"10.1097\/00043426-200205000-00021","volume":"24","author":"J-H Dalle","year":"2002","unstructured":"Dalle J-H, Auvrignon A, Vassal G, Leverger G (2002) Interaction between methotrexate and ciprofloxacin. J Pediatr Hematol Oncol 24:321\u2013322","journal-title":"J Pediatr Hematol Oncol"},{"issue":"5","key":"2485_CR12","doi-asserted-by":"publisher","first-page":"408","DOI":"10.1159\/000238444","volume":"32","author":"SB Thorsteinsson","year":"1986","unstructured":"Thorsteinsson SB, Bergan T, Oddsdottir S, Rohwedder R, Holm R (1986) Crystalluria and ciprofloxacin, influence of urinary pH and hydration. Chemotherapy 32(5):408\u2013417","journal-title":"Chemotherapy"},{"issue":"1","key":"2485_CR13","doi-asserted-by":"publisher","first-page":"228","DOI":"10.1093\/jac\/dkl196","volume":"58","author":"R Zarychanski","year":"2006","unstructured":"Zarychanski R, Wlodarczyk K, Ariano R, Bow E (2006) Pharmacokinetic interaction between methotrexate and piperacillin\/tazobactam resulting in prolonged toxic concentrations of methotrexate. J Antimicrob Chemother 58(1):228\u2013230","journal-title":"J Antimicrob Chemother"},{"issue":"1","key":"2485_CR14","doi-asserted-by":"publisher","first-page":"229","DOI":"10.1124\/jpet.106.110379","volume":"320","author":"AA El-Sheikh","year":"2007","unstructured":"El-Sheikh AA, van den Heuvel JJ, Koenderink JB, Russel FG (2007) Interaction of nonsteroidal anti-inflammatory drugs with multidrug resistance protein (MRP) 2\/ABCC2- and MRP4\/ABCC4 mediated methotrexate transport. J Pharmacol Exp Ther 320(1):229\u2013235","journal-title":"J Pharmacol Exp Ther"}],"container-title":["European Journal of Clinical Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00228-018-2485-6\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00228-018-2485-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00228-018-2485-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,5,22]],"date-time":"2019-05-22T12:16:33Z","timestamp":1558527393000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00228-018-2485-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,5,22]]},"references-count":14,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2018,9]]}},"alternative-id":["2485"],"URL":"https:\/\/doi.org\/10.1007\/s00228-018-2485-6","relation":{},"ISSN":["0031-6970","1432-1041"],"issn-type":[{"type":"print","value":"0031-6970"},{"type":"electronic","value":"1432-1041"}],"subject":[],"published":{"date-parts":[[2018,5,22]]},"assertion":[{"value":"20 March 2018","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 May 2018","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 May 2018","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Informed consent was obtained from the participant presented in the manuscript.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"The authors declare that they have no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}